Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding trial of polyethylene glycol 3350 plus electrolytes for chronic constipation
2010-021367-32Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol 3350 in chronic constipation (2 arms), sponsored by Merck & Co. Primary endpoint: Proportion of subjects with successful bowel movement within 24 hours. Started Jul 2010; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on 2010-021367-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021367-32.